Microbicide Trials Network

MTN-025 Study Specific Procedures Manual (SSPs)

DescriptionDateSize
Data Communiqué Presentations
Data Communiqué #1 Slides 2016-Oct-05338.87 KB
Individual Sections
Overview of Section Contents2017-Nov-16176.91 KB
Section 01: Introduction2017-May-18182.59 KB
Section 02: Decliner Population2016-Sep-15197.45 KB
Section 03: Documentation Requirements2017-May-18283.45 KB
Section 04: Participant Accrual, Screening and Enrollment2017-May-18329.56 KB
Section 05: Informed Consent2016-Dec-08224.3 KB
Section 06: Participant Follow-up2017-Nov-16500.6 KB
Section 07: Behavioral Assessments and ACASI User Manual2017-May-182.19 MB
Section 08: Participant Retention2016-Aug-08221.43 KB
Section 09: Study Product Considerations for Non-Pharmacy Staff2017-Nov-16394.32 KB
Section 10: Clinical Considerations2016-Dec-08402.75 KB
Section 11: Adverse Event Reporting and Safety Monitoring2017-Nov-16894.19 KB
Section 12: Counseling Considerations2017-Nov-16973.18 KB
Section 13: Laboratory Considerations2017-Nov-161.41 MB
Section 14: Data Collection2017-Nov-16784 KB
Section 15: Data Communiqués2016-Aug-08132.35 KB
Section 15: Data Communiqué #12016-Sep-19112.84 KB
Section 15: Data Communiqué #22016-Oct-21313.46 KB
Section 15: Data Communiqué #32016-Nov-2330.99 KB
Section 15: Data Communiqué #42016-Dec-01121.81 KB
Section 15: Data Communiqué #52017-Apr-1429.74 KB
Section 15: Data Communiqué #62017-Apr-21241.04 KB
Section 15: Data Communiqué #72017-Jul-3136.33 KB
Section 15: Data Communiqué #82017-Sep-2934.65 KB
Section 16: Study Reporting Plan2017-Nov-16213.65 KB
Section 17: HOPE Qualitative Component2017-Nov-161.59 MB
Section 18: HOPE CHARISMA Component2017-Jan-13135.27 KB
Trainings
HOPE SSP Updates, November 20172017-Nov-1617.16 MB